Table 6.
Variable | #positive/#tested | Percentage | Fisher’s Exact p value |
---|---|---|---|
Gender | 0.01 | ||
Male | 32/154 | 20.8% | |
Female | 73/220 | 33.2% | |
Race | 0.09 | ||
African American | 13/52 | 25.0% | |
Caucasian | 86/281 | 30.6% | |
Asian American | 0/15 | 0.0% | |
Hispanic | 1/2 | 50.0% | |
Other | 3/16 | 18.8% | |
Race, binary | 0.51 | ||
African American | 13/52 | 25.0% | |
Caucasian | 86/281 | 30.6% | |
Smoking status | <0.001 | ||
Never Smoker | 6/72 | 8.3% | |
Ever Smoker | 98/300 | 32.7% | |
Histology | 0.68 | ||
Adenocarcinoma | 88/294 | 29.9% | |
Squamous | 5/31 | 16.1% | |
Adenosquamous | 4/12 | 33.3% | |
Poorly Differentiated | 5/24 | 20.8% | |
Large Cell | 2/8 | 25.0% | |
Sarcomatoid | 0/1 | 0.0% | |
Pleomorphic | 0/1 | 0.0% | |
NOS* | 0 | -- | |
Disease Status | 0.03 | ||
Localized | 23/92 | 25.0% | |
Recurrent, extrathoracic | 6/18 | 33.3% | |
Recurrent, intrathoracic | 17/33 | 51.5% | |
Metastatic extrathoracic | 35/147 | 23.8% | |
Metastatic intrathoracic | 24/83 | 28.9% | |
Subcutaneous Mets | 0.02 | ||
No | 101/365 | 27.7% | |
Yes | 4/5 | 80.0% | |
Surgery as part of treatment | 0.05 | ||
No | 43/183 | 23.5% | |
Yes | 62/187 | 33.2% |
NOS refers to NSCLC not otherwise specified